Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study

NCT02514499 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

350

Enrollment

OTHER

Sponsor class

Conditions

BRCA1/2 Negative

Interventions

OTHER: Questionnaires

Sponsor

Abramson Cancer Center at Penn Medicine